Reuters -- Genzyme Corp said on Monday it will scrap most unfinished batches of its top-selling drug after the plant where they were being produced was contaminated by a virus, and that 2009 results will come in at the low end of its forecasts.
Reuters -- Genzyme Corp said on Monday it will scrap most unfinished batches of its top-selling drug after the plant where they were being produced was contaminated by a virus, and that 2009 results will come in at the low end of its forecasts.
